Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anjay Rastogi

Showing results (71-80 of 92) with videos related to

Pageof 10
Sort By:
Journal of the American Society of Nephrology : JASN|September 20, 2018
A Practical Guide for Treatment of Rapidly Progressive ADPKD with TolvaptanFouad T Chebib, Ronald D Perrone, Arlene B Chapman, et al.
Clinical Nephrology|May 26, 2020
Arterial stiffness and kidney disease progression in the systolic blood pressure intervention trial
Kristen L Nowak, Michel Chonchol, Anna Jovanovich, et al.
Clinical Journal of the American Society of Nephrology : CJASN|March 1, 2020
Urine Markers of Kidney Tubule Cell Injury and Kidney Function Decline in SPRINT Trial Participants with CKDRakesh Malhotra, Ronit Katz, Vasantha Jotwani, et al.
Mayo Clinic Proceedings|November 8, 2020
Clinical Management of HyperkalemiaBiff F Palmer, Juan Jesus Carrero, Deborah J Clegg, et al.
JACC. Heart Failure|November 30, 2019
Heart Failure Prevention in Older Patients Using Intensive Blood Pressure Reduction: Potential Role of DiureticsBharathi Upadhya, Laura C Lovato, Michael Rocco, et al.
Kidney360|May 7, 2025
Association of Different Definitions of Erythropoiesis-Stimulating Agent Hyporesponsiveness with Major Adverse Cardiovascular Events: Insights From ASCEND-DFinnian R Mc Causland, Sushrut S Waikar, Brian Claggett, et al.
Clinical Journal of the American Society of Nephrology : CJASN|August 2, 2022
Three Times Weekly Dosing of Daprodustat versus Conventional Epoetin for Treatment of Anemia in Hemodialysis Patients: ASCEND-TD: A Phase 3 Randomized, Double-Blind, Noninferiority TrialDaniel W Coyne, Ajay K Singh, Renato D Lopes, et al.
Hypertension (Dallas, Tex. : 1979)|February 15, 2021
Effect of Intensive Versus Standard Blood Pressure Control on Stroke SubtypesClinton B Wright, Alexander P Auchus, Alan Lerner, et al.
Hypertension (Dallas, Tex. : 1979)|December 24, 2019
Blood Pressure Control and the Association With Diabetes Mellitus Incidence: Results From SPRINT Randomized TrialChristianne L Roumie, Adriana M Hung, Gregory B Russell, et al.
Plos One|January 31, 2025
Practice patterns on the management of secondary hyperparathyroidism in the United States: Results from a modified Delphi panelDavid E Henner, Beatrice Drambarean, Teresa M Gerbeling, et al.
Pageof 10

Showing results (71-80 of 92) with videos related to

Sort By:
Pageof 10
Journal of the American Society of Nephrology : JASN|September 20, 2018
A Practical Guide for Treatment of Rapidly Progressive ADPKD with TolvaptanFouad T Chebib, Ronald D Perrone, Arlene B Chapman, et al.
Clinical Nephrology|May 26, 2020
Arterial stiffness and kidney disease progression in the systolic blood pressure intervention trial
Kristen L Nowak, Michel Chonchol, Anna Jovanovich, et al.
Clinical Journal of the American Society of Nephrology : CJASN|March 1, 2020
Urine Markers of Kidney Tubule Cell Injury and Kidney Function Decline in SPRINT Trial Participants with CKDRakesh Malhotra, Ronit Katz, Vasantha Jotwani, et al.
Mayo Clinic Proceedings|November 8, 2020
Clinical Management of HyperkalemiaBiff F Palmer, Juan Jesus Carrero, Deborah J Clegg, et al.
JACC. Heart Failure|November 30, 2019
Heart Failure Prevention in Older Patients Using Intensive Blood Pressure Reduction: Potential Role of DiureticsBharathi Upadhya, Laura C Lovato, Michael Rocco, et al.
Kidney360|May 7, 2025
Association of Different Definitions of Erythropoiesis-Stimulating Agent Hyporesponsiveness with Major Adverse Cardiovascular Events: Insights From ASCEND-DFinnian R Mc Causland, Sushrut S Waikar, Brian Claggett, et al.
Clinical Journal of the American Society of Nephrology : CJASN|August 2, 2022
Three Times Weekly Dosing of Daprodustat versus Conventional Epoetin for Treatment of Anemia in Hemodialysis Patients: ASCEND-TD: A Phase 3 Randomized, Double-Blind, Noninferiority TrialDaniel W Coyne, Ajay K Singh, Renato D Lopes, et al.
Hypertension (Dallas, Tex. : 1979)|February 15, 2021
Effect of Intensive Versus Standard Blood Pressure Control on Stroke SubtypesClinton B Wright, Alexander P Auchus, Alan Lerner, et al.
Hypertension (Dallas, Tex. : 1979)|December 24, 2019
Blood Pressure Control and the Association With Diabetes Mellitus Incidence: Results From SPRINT Randomized TrialChristianne L Roumie, Adriana M Hung, Gregory B Russell, et al.
Plos One|January 31, 2025
Practice patterns on the management of secondary hyperparathyroidism in the United States: Results from a modified Delphi panelDavid E Henner, Beatrice Drambarean, Teresa M Gerbeling, et al.
Pageof 10